Posts Tagged: R&D

23andMe to Sell Genetic Tests for Disease Risk to Consumers

It has just been announced that 23andMe has been granted permission by the FDA to sell genetic tests for disease risk directly to the public. This very interesting development  touches upon the potential growth that the biotech industry can achieve in the future. Other companies will certainly follow suit and offer competing services, but this… Tags: , , , , , ,

Categories: News

COMMUNICATION ETIQUETTE

Technology has made it so we can communicate with anyone from anywhere with the click of a button. This convenience can sometimes lead people to make simple mistakes. How you communicate with others in the work place can greatly affect how people perceive you in the office. Take these pointers below to insure you are… Tags: , , ,

Categories: Interview Tips

Alcohol Dependence – Which Path Does Your Brain Take?

THE STUDY compares alcohol-dependent brains and non-dependent brains of rats. THE OBSERVATIONS showed two different brain signaling pathways when the rats were given alcohol.  Both pathways led to the central amygdala (CeA) increasing its activity in the mice.  THE TWO PATHWAYS are caused by “a switch in the molecular mechanisms underlying the CeA’s response to… Tags: , , , , , , , , , , ,

Categories: News

Prodrugs Continue to Show Encouraging Results in Fighting Solid Tumors

Prodrugs are medications that only activate once inside the body.  The conversion happens once the inactive drug is triggered.  The metabolized drug is then able to undergo its pharmacological activity.  Prodrugs can help reduce toxicity, increase bioavailability, reduce other drug interactions, and various other benefits. Prodrugs are great for fighting cancerous tumors, especially when regular… Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

Categories: News

David M. Sabatini Wins 2017 Lurie Prize

David M. Sabatini, M.D., Ph.D., Wins 2017 Lurie Prize

David Sabatini David M. Sabatini received the fifth annual Lurie Prize in Biomedical Sciences for his discovery of the mTOR (mechanistic target of rapamycin) cellular pathway as a key regulator of growth and metabolism in response to nutrients. Dr. Sabatini’s research has identified the specific protein components of the mTOR pathway—including mTOR and two large complexes… Tags: , , , , , , , ,

Categories: Nobel Prize Winners 2017

Genetic Errors Associated with Brain Cancer Doubles

The London Institute of Cancer Research (ICR) partnered with European and US Scientists to study 30,000 participants, 12,496 with glioma and 18,190 without glioma.  The study was geared at finding changes in DNA associated with the most prevalent form of brain cancer, gliomas.  The study combined data from six previous studies to form a ‘meta-analysis’… Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Categories: News

BioScience Forum Presents- Eric Easom

Eric Easom

R&D Partners is excited to attend the BioScience Forum, volunteering monthly at the networking and presentation event. This month Eric Easom, Vice President Neglected Disease R&D Anacor Pharmaceuticals Presents on topic “Leveraging Biotech’s Novel Platforms to Tackle Global Health: A Unique Business Model to Overcome Financial Barriers”. Join R&D Partners Scientific Recruiter Michelle Blanch https://www.linkedin.com/in/michelleblanch &… Tags: , , , , ,

Categories: BioScience Forum Presents